| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.0081 | 1 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.0066 | 1 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.0038 | 1 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.0098 | 1 |